SCHEMBL9378591

SCHEMBL9378591

CC1C(=O)N(c2ccc(F)cc2)N=C1c1cccnc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ CES2 O00748 2/20 0.45
▸ APP P05067 1/20 0.44
▸ RAB9A P51151 3/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ MAPT P10636 5/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ LOX P28300 1/20 0.40
▸ LOXL3 P58215 1/20 0.40
▸ LOXL4 Q96JB6 1/20 0.40
▸ LOXL2 Q9Y4K0 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9379150 0.90 KDM4E (0.56) KDM4EL3MBTL1CES2APPRAB9A
SCHEMBL9379022 0.88 LOX (0.54) KDM4EL3MBTL1CES2APPMAPT
SCHEMBL9383881 0.88 KDM4E (0.45) KDM4EL3MBTL1CES2APPMAPT
SCHEMBL9385752 0.87 KDM4E (0.46) KDM4EL3MBTL1CES2APPRAB9A
SCHEMBL9379582 0.87 MIF (0.46) KDM4EL3MBTL1CES2APPNPC1
SCHEMBL9379114 0.86 GRM2 (0.49) KDM4EL3MBTL1CES2APPNPC1
SCHEMBL9379657 0.85 KDM4E (0.44) KDM4EL3MBTL1CES2APPMAPT
SCHEMBL9383488 0.85 MAPT (0.56) KDM4EL3MBTL1CES2APPRAB9A
SCHEMBL9378423 0.85 KDM4E (0.44) KDM4EL3MBTL1CES2APPRAB9A
SCHEMBL9378375 0.84 MKNK1 (0.51) KDM4EL3MBTL1CES2APPRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0269030-B1 Lipid-peroxide formation inhibiting composition and novel compounds useful therefor MITSUBISHI CHEM IND (JP) 1994-05-04 — — EP disclosed
US-5089515-A Antiischemic agents; pyrazolone compounds MITSUBISHI KASEI CORPORATION (JP) 1992-02-18 — — US disclosed
US-4990619-A Cardiovascular disorders, antiischemic agents MITSUBISHI KASEI CORPORATION (JP) 1991-02-05 — — US disclosed
US-4906644-A Lipid-peroxide formation inhibiting composition and novel compounds useful therefor MITSUBISHI KASEI CORPORATION (JP) 1990-03-06 — — US disclosed
EP-0269030-A2 Lipid-peroxide formation inhibiting composition and novel compounds useful therefor MITSUBISHI KASEI CORPORATION (JP) 1988-06-01 — — EP disclosed
Send feedback